These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6849781)

  • 1. An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease.
    Naranjo CA; Busto U; Janecek E; Ruiz I; Roach CA; Kaplan K
    Br J Clin Pharmacol; 1983 Apr; 15(4):451-8. PubMed ID: 6849781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug administration in chronic liver disease.
    Westphal JF; Brogard JM
    Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions (ADRs) in patients with previous history of chronic alcohol consumption without signs of chronic hepatic damage. A prospective study.
    Gonzáles-Martín G; Dominichinni H; Díaz M; Guevara A
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):20-6. PubMed ID: 7711986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furosemide-induced adverse reactions in cirrhosis of the liver.
    Naranjo CA; Pontigo E; Valdenegro C; González G; Ruiz I; Busto U
    Clin Pharmacol Ther; 1979 Feb; 25(2):154-60. PubMed ID: 759067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics or environment in drug transport: the case of organic anion transporting polypeptides and adverse drug reactions.
    Clarke JD; Cherrington NJ
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):349-60. PubMed ID: 22280100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions (ADRs) in patients with heart diseases. Comparison between patients without and with heart failure.
    Ruiz I; Ortiz M
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):595-601. PubMed ID: 6500756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The liver: a pharmacologic perspective.
    Bossone CM
    Nurs Clin North Am; 1977 Jun; 12(2):291-303. PubMed ID: 585856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dangerous drugs in hepatic insufficiency].
    Isal JP; Caulin C
    Med Chir Dig; 1979; 8(5):447-9. PubMed ID: 534025
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of hepatic insufficiency in pharmacokinetics of drugs: example for an anthranilic diuretic.
    Dreux C; Passa P; Halter D
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):289-96. PubMed ID: 552592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic basis of adverse drug reactions: the perils of inappropriate dose schedules.
    Shah RR
    Expert Opin Drug Saf; 2005 Jan; 4(1):103-28. PubMed ID: 15709902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.
    Tegeder I; Levy M; Muth-Selbach U; Oelkers R; Neumann F; Dormann H; Azaz-Livshits T; Criegee-Rieck M; Schneider HT; Hahn E; Brune K; Geisslinger G
    Br J Clin Pharmacol; 1999 May; 47(5):557-64. PubMed ID: 10336581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis.
    Franz CC; Egger S; Born C; Rätz Bravo AE; Krähenbühl S
    Eur J Clin Pharmacol; 2012 Feb; 68(2):179-88. PubMed ID: 21842337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations.
    Franz CC; Hildbrand C; Born C; Egger S; Rätz Bravo AE; Krähenbühl S
    Eur J Clin Pharmacol; 2013 Aug; 69(8):1565-73. PubMed ID: 23588561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital admissions resulting from preventable adverse drug reactions.
    McDonnell PJ; Jacobs MR
    Ann Pharmacother; 2002 Sep; 36(9):1331-6. PubMed ID: 12196047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study.
    González-Martin G; Caroca CM; Paris E
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):530-3. PubMed ID: 9799056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
    Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
    PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of awareness of community-acquired adverse drug reactions upon hospital admission : dimensions and consequences of a dilemma.
    Dormann H; Criegee-Rieck M; Neubert A; Egger T; Geise A; Krebs S; Schneider T; Levy M; Hahn E; Brune K
    Drug Saf; 2003; 26(5):353-62. PubMed ID: 12650635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs and the liver: advances in metabolism, toxicity, and therapeutics.
    Buratti S; Lavine JE
    Curr Opin Pediatr; 2002 Oct; 14(5):601-7. PubMed ID: 12352255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.